StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / aspectbiosystems.com

Aspect Biosystems

Aspect Biosystems (aspectbiosystems.com): 3 changes recorded in its website history since January 2015. Homepage last checked 5 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. MessagingBetween and
    BeforeMicrofluidic 3D Bioprinting
    Aftertransform how we treat disease

    Classifier interpretation of website text.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    Before3D BIOPRINTING AND TISSUE ENGINEERING
    AfterMicrofluidic 3D Bioprinting

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. FundingBetween and

    Announced on its homepage: “Aspect Biosystems Closes First Institutionally Led Round of Financing September 18, 2017 Aspect has announced the completion of its first…”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 9 January 2015

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Aspect Biosystems | Human Tissues on Demand

Human Tissues on Demand

Homepage

Funding statements on the website
The Aspect team is thrilled to announce that Aspect Biosystems was awarded second place and a $55,000 prize package at the prestigious BCIC New Ventures Competition! · Aspect Biosystems is excited to announce an investment in the company from the e@UBC Seed Fund.

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. September 2023 – November 2026 · 5 captures · latest observed messagingtransform how we treat disease

    Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.

    This wording observed 5 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 5 captures in this group
    • 26 September 2023 · transform how we treat disease archived page
    • 8 January 2025 · transform how we treat disease archived page
    • 14 July 2026 · transform how we treat disease archived page
    • 18 October 2026 · transform how we treat disease archived page
    • 5 November 2026 · transform how we treat disease current websiteHistorical capture not publicly available
  2. March 2018 – January 2022 · 4 capturesMicrofluidic 3D Bioprinting

    We combine the power of microfluidics and 3D bioprinting to create living, human tissues that will save lives and make people healthier.

    This wording observed 22 January 2022.

    archived page
    Inspect 4 captures in this group
  3. January 2015 – July 2016 · 2 capturesAspect Biosystems | Human Tissues on Demand

    Human Tissues on Demand

    This wording observed 16 July 2016.

    archived page
    Inspect 2 captures in this group
    • 9 January 2015 · Aspect Biosystems | Human Tissues on Demand archived page
    • 16 July 2016 · Aspect Biosystems | Human Tissues on Demand archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Aspect Biosystems funding and homepage messaging updates

Aspect Biosystems disclosed an institutionally led funding round and has updated its homepage headlines, indicating shifts in how it frames its work and technology.

  • Between July 2016 and March 2018, Aspect Biosystems announced on its homepage that it closed its first institutionally led round of financing, described as its first completed round. [1]
  • Between July 2019 and September 2020, Aspect Biosystems changed its homepage headline from “3D BIOPRINTING AND TISSUE ENGINEERING” to “Microfluidic 3D Bioprinting”. [2]
  • Between January 2022 and September 2023, a classifier read a homepage headline change from “Microfluidic 3D Bioprinting” to “transform how we treat disease” as a repositioning. [3]
  • Reading: The shifts in homepage language in the periods July 2019–September 2020 and January 2022–September 2023 may suggest a move from emphasizing specific 3D bioprinting technology toward a broader focus on disease treatment outcomes. [2][3]

Cite this record

StartupHistory, “Aspect Biosystems” company record, https://startuphistory.org/c/aspectbiosystems.com

Machine-readable: /c/aspectbiosystems.com.json. How changes are found: method.